Perceived Stress and Sexual Orientation Among Breast Cancer Survivors

2014 ◽  
Vol 61 (6) ◽  
pp. 889-898 ◽  
Author(s):  
Jennifer M. Jabson ◽  
Deborah J. Bowen
2021 ◽  
Vol 67 ◽  
pp. 102498
Author(s):  
Jesse J. Plascak ◽  
Adana A.M. Llanos ◽  
Bo Qin ◽  
Laxmi Chavali ◽  
Yong Lin ◽  
...  

2011 ◽  
Vol 29 (3) ◽  
pp. 220-228 ◽  
Author(s):  
Ulrike Boehmer ◽  
Michelle Mertz ◽  
Alison Timm ◽  
Mark Glickman ◽  
Mairead Sullivan ◽  
...  

2018 ◽  
Vol 27 (10) ◽  
pp. 2389-2397 ◽  
Author(s):  
Ulrike Boehmer ◽  
Jeffrey E. Stokes ◽  
Angela R. Bazzi ◽  
Michael Winter ◽  
Melissa A. Clark

2013 ◽  
Vol 7 (2) ◽  
pp. 203-210 ◽  
Author(s):  
Ulrike Boehmer ◽  
Mark Glickman ◽  
Michael Winter ◽  
Melissa A. Clark

2020 ◽  
Vol 15 (10) ◽  
pp. 1056-1063 ◽  
Author(s):  
Carrianne J Leschak ◽  
Janine M Dutcher ◽  
Kate E Byrne Haltom ◽  
Elizabeth C Breen ◽  
Julienne E Bower ◽  
...  

Abstract Chronic inflammation in women diagnosed with breast cancer is critically linked with tumor progression, metastasis and survival. C-reactive protein (CRP)—a circulating marker of inflammation—is an important prognostic marker for cancer-related outcomes in breast cancer survivors (e.g. recurrence, fatigue). Psychological stress, which increases circulating markers of inflammation following sympathetic nervous system (SNS) activation, may modulate tumor-relevant inflammatory processes. However, little is known about neural mechanisms that might link stress and downstream SNS-initiated proinflammatory processes, such as elevated CRP. Past work suggests that threat-related neural regions, such as the amygdala, may be key in translating psychological stress into SNS activity and subsequent peripheral inflammation. Thus, we examined amygdala reactivity to socially threatening stimuli in association with perceived stress and plasma CRP levels to further elucidate neuro-immune pathways of social threat processing within breast cancer survivors (N = 37). Significant positive correlations were found between left amygdala reactivity in response to socially threatening stimuli (e.g. angry/fearful faces vs happy faces) and perceived stress in the previous month (r = 0.32, P = 0.025) and between left amygdala reactivity and CRP (r = 0.33, P = 0.025). This work builds on prior research implicating the amygdala as a key structure in crosstalk between threat-related neural circuitries and peripheral inflammation, particularly within cancer survivors.


2020 ◽  
Author(s):  
Cecile A. Lengacher ◽  
L. Forest Gruss ◽  
Kevin E. Kip ◽  
Richard R. Reich ◽  
Manolete S. Moscoso ◽  
...  

ABSTRACTMBSR(BC) is known to have a positive impact on psychological and physical symptoms among breast cancer survivors (BCS). However, the cognitive mechanisms of “how” MBSR(BC) works are unknown. The purpose of this study, as part of a larger R01 trial, was to test whether positive effects achieved from the MBSR(BC) program were mediated through changes in increased mindfulness, decreased fear of breast cancer recurrence, and perceived stress. Female BCS >21 years diagnosed with Stage 0-III breast cancer were randomly assigned to a 6-week MBSR(BC) or a Usual Care(UC) regimen. Potential outcome mediators were identified by use of an analysis of covariance (ANCOVA), comparing mean values of outcome variables and potential mediating variables followed by mediational and bootstrap analyses. Among 322 BCS (167 MBSR(BC) and 155 UC), fear of recurrence and perceived stress, but not mindfulness, mediated reductions in anxiety and fatigue at weeks 6 and 12, partially supporting our hypothesis of cognitive mechanisms of MBSR(BC).Support: This study was supported by the National Cancer Institute (Award Number 1R01 CA131080-01A2). This work also has been supported in part by the Biostatistics and Bioinformatics Shared Resource at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center (P30-CA076292). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This study protocol was approved by the Institutional Review Board at the University of South Florida to ensure the ethical treatment of participants.Conflict of Interest: The authors have no conflicts to report.Trial Registration:www.ClinicalTrials.gov Registration Number: NCT01177124


Sign in / Sign up

Export Citation Format

Share Document